SEC Company Response from TELA Bio, Inc. (TELA) (CIK 0001561921) (TELA) — Nov 5, 2019
TELA Bio, Inc. (TELA) (CIK 0001561921)
Date: Nov. 5, 2019 · CIK: 0001561921 · Accession: 0001104659-19-060050
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-234217
Letter
TELA Bio, Inc. 1 Great Valley Parkway, Suite 24 Malvern, Pennsylvania 19355
November 5, 2019
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Manufacturing
100 F Street NE
Washington, D.C. 20549
Attn: Tara Harkins, Lynn Dicker, Thomas Jones and Geoff Kruczek
Re: TELA Bio, Inc. Registration Statement on Form S-1 SEC File No. 333-234217 Filed October 29, 2019
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, TELA Bio, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-1 (File No. 333-234217) (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:00 PM, eastern time, on November 7, 2019, or as soon thereafter as is practicable.
Please feel free to direct any questions or comments concerning this request to Rachael Bushey, Esq. of Pepper Hamilton LLP at (215) 981-4331.
The Company understands that the staff of the United States Securities and Exchange Commission will consider this request as confirmation by the Company that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
TELA BIO, INC.
By:
/s/ Antony Koblish
Name: Antony Koblish
Title: President, Chief Executive Officer
Cc: Rachael Bushey, Pepper Hamilton LLP
Show Raw Text
CORRESP 1 filename1.htm TELA Bio, Inc. 1 Great Valley Parkway, Suite 24 Malvern, Pennsylvania 19355 November 5, 2019 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Manufacturing 100 F Street NE Washington, D.C. 20549 Attn: Tara Harkins, Lynn Dicker, Thomas Jones and Geoff Kruczek Re: TELA Bio, Inc. Registration Statement on Form S-1 SEC File No. 333-234217 Filed October 29, 2019 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, TELA Bio, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-1 (File No. 333-234217) (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:00 PM, eastern time, on November 7, 2019, or as soon thereafter as is practicable. Please feel free to direct any questions or comments concerning this request to Rachael Bushey, Esq. of Pepper Hamilton LLP at (215) 981-4331. The Company understands that the staff of the United States Securities and Exchange Commission will consider this request as confirmation by the Company that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement. TELA BIO, INC. By: /s/ Antony Koblish Name: Antony Koblish Title: President, Chief Executive Officer Cc: Rachael Bushey, Pepper Hamilton LLP